Mergers, acquisitions and divestitures have always been part of the MedTech industry’s growth story. But the current cycle is different.

This is no longer a market defined by occasional headline transactions or opportunistic portfolio moves.

In today’s M&A market – where deals are under more pressure to deliver real value, faster – Capgemini brings a perspective that goes well beyond traditional PMI.

Learn how Capgemini helps MedTech organisations not just integrate or separate, but rethink how they operate, scale, and grow in the process.